Manufacturers Life Insurance Company, The Astria Therapeutics, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $103 Billion
- Q1 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Astria Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 17,156 shares of ATXS stock, worth $155,776. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,156
Previous 14,925
14.95%
Holding current value
$155,776
Previous $114,000
111.4%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ATXS
# of Institutions
122Shares Held
48.8MCall Options Held
3.59MPut Options Held
483K-
Perceptive Advisors LLC New York, NY6.49MShares$58.9 Million1.91% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.28MShares$47.9 Million7.82% of portfolio
-
Vr Adviser, LLC New York, NY3.61MShares$32.8 Million4.36% of portfolio
-
Black Rock Inc. New York, NY3.59MShares$32.6 Million0.0% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA3.55MShares$32.3 Million7.97% of portfolio
About Astria Therapeutics, Inc.
- Ticker ATXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,178,000
- Market Cap $138M
- Description
- Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...